More patients than previously reported may experience hearing symptoms such as hearing loss or muffled hearing from a new treatment for thyroid eye disease, teprotumumab (Tepezza), according to a small study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.Read more
Realizing that wearing a mask can make communication harder for people with hearing loss, Rush University Medical Center is now offering transparent face masks. These clear masks can help ease stressful situations and it make it less likely for information to be misinterpreted.Read more
Researchers will be dedicated to battling hearing loss resulting from numerous causes. They will tackle hearing loss in children whose hearing is compromised by antibiotics or other medical treatments, to persons suffering hearing loss in the wake of cancer therapies, those who suffer deafness due to such infections as meningitis, through to natural hearing loss caused by aging.Read more
Eighty percent of Americans over 50 say their primary care doctor hasn’t asked about their hearing in the past two years, and nearly as many haven’t had their hearing checked by a professional in that same time, according to a new national poll report.Read more
DETROIT (December 23, 2020) – This holiday season, Angela Holland will enjoy the gift of hearing from her left ear again. After 50 years of single-sided deafness caused by a disease known as cholesteatoma, new hearing technology implanted by Henry Ford Health System surgeon Kristen Angster, M.D. will allow Holland to ring in the season and truly enjoy the sounds of the holidays.Read more
Researchers report that hearing loss and high blood sugar are associated with poor cognitive performance among middle-aged and older Latinos.Read more
Mass Eye and Ear is proud to announce the successful conclusion of its historic campaign, “Bold Science. Life-Changing Cures.” which raised $252M from philanthropy to advance research to treat and cure diseases of vision, hearing, and the head and neck.
The campaign was led by co-chair Wyc Grousbeck, Boston Celtics CEO and Lead Owner and former Chairman of Mass Eye and Ear.
Thomas Balkany, M.D., Hotchkiss professor and chair emeritus of the Department of Otolaryngology at the University of Miami Miller School of Medicine, is the first recipient of the annual Noel L. Cohen Award from the American Neurotology Society (ANS). Dr. Balkany was recognized during ANS’s Annual Meeting on September 11.Read more
With six mutations in genes associated with hearing, naked mole-rats can barely hear the constant squeaking they use to communicate with one another. This hearing loss, which is strange for such social, vocal animals, is an adaptive, beneficial trait, according to new findings published in the journal Current Biology.Read more
An international group of hearing specialists has released a new set of recommendations emphasizing that cochlear implants should be offered to adults who have moderate to severe or worse hearing loss much more often than is the current practice. The group hopes the recommendations help increase usage of such devices, potentially improving hearing and quality of life for millions worldwide.Read more
Opioid receptors in the inner ear can cause partial or full hearing loss, says Rutgers studyRead more
Scientists at St. Jude Children’s Research Hospital are studying how hearing loss can affect the neurocognitive abilities of childhood cancer survivors. Findings show that survivors with severe hearing loss are at a significant increased risk for neurocognitive deficits, independent of what type of therapy they receive.Read more
In a new study of human ear tissues, hearing scientists have demonstrated that age-related hearing loss, also called presbycusis, is mainly caused by damage to hair cells, the sensory cells in the inner ear that transform sound-induced vibrations into the electrical signals that are relayed to the brain by the auditory nerve. Their research challenges the prevailing view of the last 60 years that age-related hearing loss is mainly driven by damage to the stria vascularis, the cellular “battery” that powers the hair cell’s mechanical-to-electrical signal conversion.Read more
Sharon Tapp, who worked as a nurse case manager at Veterans Affairs Medical Center in Washington, D.C., started experiencing sudden body weakness, chest pain, a high temperature and headache on March 18. Concerned, she went to her local urgent care center to find out what was wrong. They told her that these symptoms were flu-like, tested her for the coronavirus and told her to quarantine for 14 days. After five days and no difference in the presentation of her symptoms, the urgent care team contacted Sharon, letting her know that she tested positive for coronavirus and recommending that she go to the emergency department. Sharon’s family took her to Johns Hopkins Medicine’s Suburban Hospital. Because her condition worsened while at Suburban, she was transferred to The Johns Hopkins Hospital in Baltimore within 10 days of being admitted to Suburban Hospital.Read more
Mount Sinai research highlights the need for more hearing checks among groups at high risk for fallsRead more
Sarah Mowry, MD, is a board certified neurotologist at University Hospitals Cleveland Medical Center, and treats patients with disorders ofRead more
A pair of biomarkers of brain function — one that represents “listening effort,” and another that measures ability to process rapid changes in frequencies — may help to explain why a person with normal hearing may struggle to follow conversations in noisy environments, according to a new study led by Massachusetts Eye and Ear researchers. The researchers hoped the study could inform the design of next-generation clinical testing for hidden hearing loss, a condition that cannot currently be measured using standard hearing exams.Read more
Mass. Eye and Ear scientists report the identification of a new pathway linked to cell division in the ear. With this pathway, they were able to reprogram the inner ear’s cells to proliferate and regenerate hair cell-like cells in adult mouse models.
Northern Arizona University professor O’neil Guthrie is testing a drug designed to help the body’s natural ability to repair DNA to determine whether it can help repair cells damaged by noise and help prevent hearing loss.Read more